Wall Street Analysts See a 54.78% Upside in Arcutis Biotherapeutics, Inc. (ARQT): Can the Stock Really Move This High?

Arcutis Biotherapeutics, Inc. (ARQT) closed the last trading session at $10.66, gaining 14.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $16.50 indicates a 54.8% upside potential.The mean estimate comprises six short-term price targets with a standard deviation of $6.44. While the lowest estimate of $8 indicates a 25% decline from the current price level, the most optimistic a ...